Back to Screener

Healthcare

Celldex Therapeutics Inc(CLDX)

Live Price

Offline

$34.08

+0.87% today

1Y Change

+55.79%

Window

Jun 26, 2025 โ†’ Jun 23, 2026

Market Cap
$2.25B
Revenue Growth
-78.6%
EPS Growth
-59.2%
Dividend Yield
0.0%

Coverage: 248 bars ยท Jun 26, 2025 โ†’ Jun 23, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Celldex Therapeutics Inc (CLDX) is a Healthcare stock with a market cap of $2.25B and listed on NASDAQ. The stock last traded around $34.08 and up 55.8% across the available one-year price window (Jun 26, 2025 โ†’ Jun 23, 2026). Baseline metrics include revenue growth of -78.6%, EPS growth of -59.2%, a dividend yield of 0.0%. What stands out right now is revenue -78.6%, EPS -59.2%, free cash flow -33.8% with operating margin -19160.0% and ROIC -53.9%. Valuation already assumes a fairly strong business story at price/sales 1502.7. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CLDX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

CLDX vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

CLDX

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

CLDX Max Drawdown

-24.23%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for CLDX and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 14, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 14, 26
โ€”
Est -1.10
โ€”
โ€”
Est 795.4B
โ€”
May 14
โ€”
Feb 25, 26
โœ—
-1.22
Est -1.00
-22.0%
100.0B
Est 1316.1B
-92.4%
Feb 25
โ€”
Nov 10, 25
โœ—
-1.01
Est -0.88
-14.8%
โ€”
Est 1532.8B
โ€”
Nov 10
โ€”
Aug 7, 25
โœ“
-0.85
Est -0.86
+1.2%
730.0B
Est 1183.9B
-38.3%
Aug 7
โ€”
May 8, 25
โœ—
-0.81
Est -0.75
-8.0%
695.0B
Est 1120.8B
-38.0%
May 8
โ€”
Feb 27, 25
โœ“
-0.71
Est -0.73
+2.7%
1175.0B
Est 1252.0B
-6.2%
Feb 27
โ€”
Nov 6, 24
โœ“
-0.64
Est -0.69
+7.3%
3191.0B
Est 1090.0B
+192.8%
Nov 6
โ€”
Aug 8, 24
โœ“
-0.54
Est -0.59
+8.5%
2498.0B
Est 820.0B
+204.6%
Aug 8
โ€”
May 6, 24
โœ“
-0.56
Est -0.67
+16.4%
156.0B
Est 920.0B
-83.0%
May 6
โ€”
Feb 26, 24
โœ“
-0.57
Est -0.76
+25.0%
4131.0B
Est 840.0B
+391.8%
Feb 26
โ€”
Nov 2, 23
โœ—
-0.81
Est -0.67
-20.9%
1517.0B
Est 920.0B
+64.9%
Nov 2
โ€”
Aug 8, 23
โ€”
-0.65
Est -0.65
0.0%
268.0B
Est 530.0B
-49.4%
Aug 8
โ€”
May 4, 23
โœ“
-0.62
Est -0.63
+1.6%
967.0B
Est 410.0B
+135.8%
May 4
โ€”
Feb 28, 23
โœ“
-0.56
Est -0.59
+5.1%
1613.0B
Est 264.0B
+511.0%
Feb 28
โ€”
Nov 9, 22
โ€”
-0.57
Est -0.57
0.0%
407.0B
Est 360.0B
+13.1%
Nov 9
โ€”
Aug 8, 22
โœ—
-0.58
Est -0.43
-34.9%
163.0B
Est 400.0B
-59.3%
Aug 8
โ€”
May 5, 22
โœ—
-0.49
Est -0.46
-6.5%
174.0B
Est 560.0B
-68.9%
May 5
โ€”
Feb 28, 22
โœ—
-0.43
Est -0.42
-2.4%
333.0B
Est 1036.0B
-67.9%
Feb 28
โ€”
Nov 9, 21
โœ—
-0.39
Est -0.35
-11.4%
153.0B
Est 640.0B
-76.1%
Nov 9
โ€”
Aug 5, 21
โœ“
-0.34
Est -0.40
+15.0%
3480.0B
Est 685.0B
+408.0%
Aug 5
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener